J&J taps tiny Bioasis for tech to cross blood-brain barrier

Johnson & Johnson has turned to Bioasis for help getting drugs across the blood-brain barrier (BBB). The deal grants J&J’s Janssen the chance to use a human transport protein to shuttle drug molecules across the barrier to targets in the brain.